Short-distance walking speed and timed walking distance: redundant measures for clinical trials?

Neurology
B H Dobkin

Abstract

The velocity of a 15-meter walk and walking endurance (distance covered in 6 minutes) are considered distinct outcomes in clinical trials of stroke rehabilitation. Comfortable velocities used for each task in 24 subjects with chronic hemiparesis were not significantly different, however. Although speed and endurance did not reflect different domains of efficacy in outpatients whose usual speed was >0.5 m/s, the fastest feasible 15-meter velocity augmented these measures.

Citations

Jul 3, 2013·Archives of Physical Medicine and Rehabilitation·Peter A AltenburgerArlene A Schmid
Oct 3, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Sharon Barak, Pamela W Duncan
Feb 8, 2008·Nature Clinical Practice. Neurology·Bruce H Dobkin
Oct 2, 2008·Spine·Jan MehrholzMarcus Pohl
Nov 12, 2009·BMJ : British Medical Journal·Julien DumurgierChristophe Tzourio
Jun 23, 2011·Therapeutic Advances in Neurological Disorders·Andrew R Blight
Sep 10, 2014·Journal of Neurologic Physical Therapy : JNPT·Michal KafriJudith E Deutsch
Oct 4, 2011·Stroke Research and Treatment·M IosaS Paolucci
Oct 27, 2011·Journal of Neurologic Physical Therapy : JNPT·Catherine E LangMaurizio Corbetta
Dec 15, 2015·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·Hyun-Gyu Cha, Duck-Won Oh
Sep 20, 2012·Archives of Physical Medicine and Rehabilitation·Giovanni MoroneMarco Iosa
Mar 17, 2012·Archives of Physical Medicine and Rehabilitation·Ulrik DalgasKristian Overgaard
Mar 27, 2012·Archives of Physical Medicine and Rehabilitation·Marghuretta D BlandCatherine E Lang
Dec 29, 2010·Archives of Physical Medicine and Rehabilitation·Suzanne S KuysTerry P Haines
Mar 3, 2009·Lancet·Andrew D GoodmanUNKNOWN Fampridine MS-F203 Investigators
Jan 30, 2008·Archives of Physical Medicine and Rehabilitation·Gilles D CatyThierry M Lejeune
May 9, 2008·Journal of Evaluation in Clinical Practice·James E GrahamKenneth J Ottenbacher
Jan 1, 2015·IEEE Access : Practical Innovations, Open Solutions·Gina SprintVladimir Borisov
Aug 28, 2015·Nursing & Health Sciences·SeungHeon AnGyuChang Lee
May 3, 2008·Archives of Physical Medicine and Rehabilitation·James E GrahamKenneth J Ottenbacher
Aug 26, 2015·Journal of Physiotherapy·Mark R Elkins
Oct 16, 2013·Annals of Physical and Rehabilitation Medicine·J-M CasillasV Gremeaux
Apr 26, 2016·Archives of Physical Medicine and Rehabilitation·Keith LohseCatherine E Lang
Nov 28, 2008·Neurorehabilitation and Neural Repair·Hubertus J A van Hedel, UNKNOWN EMSCI Study Group
Sep 29, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Domien GijbelsPeter Feys
Jul 31, 2013·Neurorehabilitation and Neural Repair·Michal KafriJudith E Deutsch
Mar 14, 2007·Neurorehabilitation and Neural Repair·Hubertus J A van HedelArmin Curt
May 18, 2007·Neurorehabilitation and Neural Repair·John F DitunnoUNKNOWN Spinal Cord Injury Locomotor Trial Group
Oct 13, 2011·Neurorehabilitation and Neural Repair·Bruce H Dobkin, Andrew Dorsch
Feb 23, 2008·Stroke; a Journal of Cerebral Circulation·Aileen P McGinnSylvia Wassertheil-Smoller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.